PacaƱa, Berlinda S.
HRN: 23-65-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/09/2023
09/13/2023
IV
500
OD
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes